CapnoPharm is a global technology-driven CRO based in Germany offering integrated Research and development services, from formulation development, stability studies to drug-device compatibility testing for aerosolization.

Our services are based on a growing body of evidence surrounding locoregionally applied therapies by way of aerosol drug delivery – such as PIPAC^®.

CapnoPharm is committed to advancing cancer care and improving the health and well-being of patients around the world – for the greatest possible quality of life.